Company profile for Akrikhin

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Akrikhin is one of the leading Russian pharmaceutical companies that produce effective, affordable, and high-quality pharmaceuticals in the most popular therapeutic areas in Russia. The company’s portfolio totals around 200 pharmaceuticals, with more than 45 % classified as vital and essential drugs. The pharmaceuticals fall within the key pharmacotherapeutic groups, such as dermatology, gynecology, pulmonology, endocrinolog...
Akrikhin is one of the leading Russian pharmaceutical companies that produce effective, affordable, and high-quality pharmaceuticals in the most popular therapeutic areas in Russia. The company’s portfolio totals around 200 pharmaceuticals, with more than 45 % classified as vital and essential drugs. The pharmaceuticals fall within the key pharmacotherapeutic groups, such as dermatology, gynecology, pulmonology, endocrinology, cardiology, neurology, etc., and are produced in total compliance with the GMP standards.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Russia
Address
Address
9, Zemlyanoy val str., Moscow, 105064
Telephone
Telephone
+7 4957213697
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty